IDEX REPORTS SECOND QUARTER RESULTS

July 30, 2025

Highlights
(All comparisons are against the prior year period unless otherwise noted)

Record sales of $865 million increased 7% and 1% organically
Reported diluted EPS of $1.74 declined 6%, and adjusted diluted EPS of $2.07 was relatively flat year-over-year, exceeding second quarter expectations
Orders of $830 million increased 7% on a reported basis and 2% organically, below the year-to-date average
Revising full year EPS outlook to GAAP diluted EPS of $6.30 – $6.44 and adjusted diluted EPS of $7.85 – $7.95
Remain highly confident in the sustainable value creation engine IDEX is building through our integrated growth strategies and a balanced capital deployment strategy

NORTHBROOK, IL, July 30, 2025– IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2025.

“IDEX teams once again delivered strong execution in the second quarter in what continues to be a challenging operating environment,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President.

“Order trends in our rapid-turn businesses downshifted slightly exiting the second quarter although current levels suggest a steady sequential progression into the third quarter. That said, in this uncertain macro-environment, several customers are taking a more cautious stance on larger orders that has delayed the expected second-half acceleration in parts of our recently-acquired businesses. Taken together, we are resetting our baseline financial assumptions for the remainder of 2025.

Despite this near-term volatility, I am excited about how our strong culture of 8020, breadth of market exposure, and ability to tune our capabilities with agility and speed for our customers in advantaged markets positions IDEX extremely well to deliver consistent and attractive shareholder value over the long term.”

Full Year and Third Quarter 2025 Guidance

In 2025, the Company now expects to generate GAAP diluted EPS of $6.30 – $6.44 (adjusted diluted EPS of $7.85 – $7.95) a change from previous guidance of $6.56 – $6.95 (adjusted diluted EPS of $8.10 – $8.45), based on expected full year organic sales growth of approximately 1%. In the third quarter 2025, the Company expects to generate GAAP diluted EPS of $1.54 – $1.61 (adjusted diluted EPS of $1.90 – $1.95), based on expected third quarter 2025 organic sales growth of 2% to 3%.